首页> 外文期刊>World Journal of Surgical Oncology >Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer
【24h】

Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer

机译:术后C-反应蛋白/白蛋白比例作为胃癌胃癌胃癌后短期并发症的新型预测因子

获取原文
           

摘要

Postoperative complications following gastric cancer resection remain a clinical problem. Early detection of postoperative complications is needed before critical illness develops. The purpose of this study was to evaluate the prognostic value of C-reactive protein/albumin ratio in patients with gastric cancer. A total of 322 patients undergoing curative (R0) gastrectomy between 2015 and 2017 were retrospectively analyzed. Univariate and multivariate analyses were performed to identify clinical factors predicting postoperative complications. The cutoff values and diagnostic accuracy of C-reactive protein/albumin ratio and C-reactive protein were determined by receiver-operating characteristic curves. Among all of the patients, 85 (26.4%) developed postoperative complications. The optimal cutoff of C-reactive protein/albumin ratio was set at 3.04 based on the ROC analysis. Multivariate analysis identified C-reactive protein/albumin ratio was an independent risk factors for complications after gastrectomy (OR 3.037; 95% CI 1.248–7.392; P?=?0.014). Additionally, C-reactive protein/albumin ratio showed a higher diagnostic accuracy than C-reactive protein on postoperative day 3 (AUC: 0.685 vs 0.660; sensitivity: 0.624 vs 0.471; specificity: 0.722 vs 0.835). Elevated C-reactive protein/albumin ratio was an independent predictor for postoperative complications following gastrectomy of gastric cancer, and the diagnostic accuracy was higher than C-reactive protein alone. Overall, postoperative C-reactive protein/albumin ratio may help to identify patients with high probability of postoperative complications.
机译:胃癌切除后术后并发症仍然是临床问题。在危重疾病发展之前需要早期检测术后并发症。本研究的目的是评估胃癌患者C反应蛋白/白蛋白比例的预后值。回顾性分析了2015年至2017年间患有治愈性(R0)胃切除术的322名患者。进行单变量和多变量分析以确定预测术后并发症的临床因素。通过接收器操作特性曲线测定C反应蛋白/白蛋白比和C反应蛋白的截止值和诊断精度。在所有患者中,85例(26.4%)发育术后并发症。基于ROC分析,在3.04设定了C反应蛋白/白蛋白比的最佳截止。多变量分析确定的C反应蛋白/白蛋白比例是胃切除术后并发症的独立危险因素(或3.037; 95%CI 1.248-7.392; p?= 0.014)。另外,C反应蛋白/白蛋白比在术后第3天(AUC:0.685 Vs 0.660;灵敏度:0.624 Vs 0.471;特异性:0.722 vs 0.835)的C-反应性蛋白质比诊断精度高于C-反应性蛋白质。升高的C反应蛋白/白蛋白比是胃癌胃癌后术后并发症的独立预测因子,并且诊断精度单独高于C反应蛋白。总体而言,术后C反应蛋白/白蛋白比率可能有助于鉴定术后并发症巨大概率的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号